366 Chapter 12 111. Fulong X, Spruyt K, Chao L, Dianjiang Z, Jun Z, Fang H. Resting-state brain network topological properties and the correlation with neuropsychological assessment in adolescent narcolepsy. Sleep. 2020;43(8). 112. Xu L, Xue R, Ai Z, Huang Y, Liu X, Wang L, et al. Resting-State Functional Magnetic Resonance Imaging as an Indicator of Neuropsychological Changes in Type 1 Narcolepsy. Acad Radiol. 2024;31(1):69-81. 113. Wu L, Zhan Q, Liu Q, Xie S, Tian S, Xie L, Wu W. Abnormal Regional Spontaneous Neural Activity and Functional Connectivity in Unmedicated Patients with Narcolepsy Type 1: A Resting-State fMRI Study. Int J Environ Res Public Health. 2022;19(23). 114. Drissi NM, Szakacs A, Witt ST, Wretman A, Ulander M, Stahlbrandt H, et al. Altered Brain Microstate Dynamics in Adolescents with Narcolepsy. Front Hum Neurosci. 2016;10:369. 115. Jarvela M, Raatikainen V, Kotila A, Kananen J, Korhonen V, Uddin LQ, et al. Lag Analysis of Fast fMRI Reveals Delayed Information Flow Between the Default Mode and Other Networks in Narcolepsy. Cereb Cortex Commun. 2020;1(1):tgaa073. 116. Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci. 2011;15(10):483-506. 117. Schwartz S, Ponz A, Poryazova R, Werth E, Boesiger P, Khatami R, Bassetti CL. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain. 2008;131(Pt 2):514-22. 118. Meletti S, Vaudano AE, Pizza F, Ruggieri A, Vandi S, Teggi A, et al. The Brain Correlates of Laugh and Cataplexy in Childhood Narcolepsy. J Neurosci. 2015;35(33):11583-94. 119. Juvodden HT, Alnaes D, Lund MJ, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Hypocretin-deficient narcolepsy patients have abnormal brain activation during humor processing. Sleep. 2019;42(7). 120. Pomares FB, Boucetta S, Lachapelle F, Steffener J, Montplaisir J, Cha J, et al. Beyond sleepy: structural and functional changes of the default-mode network in idiopathic hypersomnia. Sleep. 2019;42(11). 121. Lammers GJ. Drugs Used in Narcolepsy and Other Hypersomnias. Sleep Med Clin. 2022;17(3):399-405. 122. Thorpy MJ, Dauvilliers Y. Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Med. 2015;16(1):9-18. 123. Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, et al. European guideline and expert statements on the management of narcolepsy in adults and children. J Sleep Res. 2021;30(6):e13387. 124. Black J, Pardi D, Hornfeldt CS, Inhaber N. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebocontrolled study in patients with narcolepsy. J Clin Sleep Med. 2010;6(6):596-602. 125. Thannickal TC, John J, Shan L, Swaab DF, Wu MF, Ramanathan L, et al. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy. Sci Transl Med. 2018;10(447). 126. Donjacour C, Lammers GJ, Siegel JM. Striking cessation of cataplexy by opioids. J Sleep Res. 2019;28(4):e12781. 127. Wichniak A, Brunner H, Friess E, Pollmacher T. Successful suppression of cataplectic attacks with tramadol. Neurology. 2003;61(6):864-5. 128. Anderson MW, Zendell SM, Morgan JP, Herrera CO, Rubinstein ML, Spielman AJ. The effects of methadone in narcolepsy. Presented at: 5th international congress of sleep research; 28 June - 3 July 1987; Copenhagen, Denmark. 1987.
RkJQdWJsaXNoZXIy MjY0ODMw